[{"AccountsPayableCurrent_0_Q3_USD":11024000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":107725000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5500000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":512000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-717000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-154000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":871000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":238000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":751000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":238000.0,"OtherAssetsNoncurrent_0_Q3_USD":4751000.0,"ProceedsFromSaleOfProductiveAssets_3_Q3_USD":62010000.0,"OtherAssetsCurrent_0_Q3_USD":2799000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.076,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2802000.0,"OperatingLeasePayments_3_Q3_USD":1641000.0,"OperatingLeasePayments_1_Q3_USD":548000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":654000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1849000.0,"OperatingLeaseLiability_0_Q3_USD":2503000.0,"OperatingLeaseCost_3_Q3_USD":1936000.0,"OperatingLeaseCost_1_Q3_USD":644000.0,"OperatingIncomeLoss_3_Q3_USD":-79675000.0,"OperatingIncomeLoss_1_Q3_USD":-28704000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-18382000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":642000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-28858000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":489000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1846000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":43019217.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":43598350.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":248000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":140492.0,"StockholdersEquity_0_Q3_USD":210845000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":33.02,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":39.46,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":3.48,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":23.46,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":5805545.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":62545000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":20.85,"ProfitLoss_3_Q3_USD":-18382000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":20.19,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":102000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":39063.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":13.09,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":3526547.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":59260000.0,"ShareBasedCompensation_3_Q3_USD":14426000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":39433000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":13988000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":25299000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":8965000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-303582000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":64488000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":23131000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":311000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":43598350.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-18382000.0,"NetIncomeLoss_3_Q3_USD":-18382000.0,"EarningsPerShareBasic_1_Q3_USD":-0.66,"DividendsCommonStock_3_Q3_USD":0.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3_Q3_USD":62010000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":491000.0,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CostsAndExpenses_3_Q3_USD":104974000.0,"CostsAndExpenses_1_Q3_USD":37669000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":843000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":550000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-17631000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-28620000.0,"CommonStockValue_0_Q3_USD":4000.0,"EarningsPerShareBasic_3_Q3_USD":-0.43,"CommonStockSharesIssued_0_Q3_shares":43643916.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":101096000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":215730000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":215730000.0,"AssetsCurrent_0_Q3_USD":230580000.0,"Assets_0_Q3_USD":239979000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5832317.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":4901000.0,"AdditionalPaidInCapital_0_Q3_USD":514198000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":225000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":12486000.0,"AccountsReceivableNetCurrent_0_Q3_USD":7264000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-28858000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.66,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":77000.0,"NetIncomeLoss_1_Q3_USD":-28858000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-68693000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":61498000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":108214000.0,"LiabilitiesCurrent_0_Q3_USD":25359000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":239979000.0,"Liabilities_0_Q3_USD":29134000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":228000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":542000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":539000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":64000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1586000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":2731000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.43,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":4711000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":76000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":1461000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":-4930000.0,"IncreaseDecreaseInInventories_3_Q3_USD":4787000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":7264000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1652000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-18382000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-28858000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-751000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q3_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"InventoryNet_0_Q3_USD":4787000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":43019217.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]